Health
COVID and cancer therapeutics: clinical trial and treatment disruption – European Pharmaceutical Review
EPR’s Hannah Balfour discusses how COVID-19 has impacted the pharma industry with regard to cancer clinical trial and treatment disruptions.
Posted: 19 February 2021 | Hannah Balfour (European Pharmaceutical Review) | No comments yet
In this article, European Pharmaceutical Reviews Hannah Balfour discusses how COVID-19 has impacted the pharma industry with regard to cancer clinical trial and treatment disruptions.
THE UNPRECEDENTED impact of COVID-19 has been far reaching, but the effects on cancer patients makes them one of the worst affected groups. Being immunocompromised, which is one of the most common effects associated with cancer…
-
General7 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News16 hours agoRainbow Beach surfer’s untold 7/7 story
-
General23 hours agoParis opens River Seine for public swimming for first time since 1923
-
General22 hours agoWest Indies vs Australia live: Second Test, day three from Grenada